M(6)A Modifier-Mediated Methylation Characterized by Diverse Prognosis, Tumor Microenvironment, and Immunotherapy Response in Hepatocellular Carcinoma

OBJECTIVE: Emerging evidence highlights the clinical implications of N(6)-methyladenosine (m(6)A) modification in HCC. Yet, the roles of m(6)A modification in modulating cancer immunity and shaping tumor microenvironment (TME) are undefined in hepatocellular carcinoma (HCC). METHODS: Here, m(6)A mod...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fei, Zhang, Xinyue, Liu, Ziyu, Cai, Weiye, Song, Chao, Jiang, Yan, Yin, Ji, Liu, Zongchao, Huang, Chenyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398803/
https://www.ncbi.nlm.nih.gov/pubmed/36016585
http://dx.doi.org/10.1155/2022/2513813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9398803/
https://www.ncbi.nlm.nih.gov/pubmed/36016585
http://dx.doi.org/10.1155/2022/2513813

Ejemplares similares